EyePoint Pharmaceuticals所有资讯

EyePoint Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-The Vanguard Group(5.69%)

01:00

EyePoint Pharmaceuticals | SC 13G：超过5%持股股东披露文件-BlackRock, Inc.(7.8%)

10/23 03:32

EyePoint Pharmaceuticals | 3：首次持股声明-董事 Hassan Fred

09/06 04:08

EyePoint Pharmaceuticals | 4：持股变动声明-董事 Hassan Fred

09/06 04:08

EyePoint Pharmaceuticals | 4：持股变动声明-董事 DICICCO WENDY F

08/22 04:36

EyePoint Pharmaceuticals | 4：持股变动声明-董事 ANDO GORAN

08/22 04:06

EyePoint Pharmaceuticals | 4：持股变动声明-董事 Zaderej Karen L.

08/22 04:05

EyePoint Pharmaceuticals | 4：持股变动声明-董事 Lurker Nancy

08/21 04:09

EyePoint Pharmaceuticals | 4：持股变动声明-董事 Lurker Nancy

07/27 04:49

EyePoint Pharmaceuticals | 4：持股变动声明-董事 GUYER DAVID R

07/17 04:28

EyePoint Pharmaceuticals | 4：持股变动声明-高管 Duker Jay S.

07/13 05:08

EyePoint Pharmaceuticals | 4：持股变动声明-高管 Lurker Nancy

07/13 05:07

EyePoint Pharmaceuticals | 4：持股变动声明-董事 Zaderej Karen L.

07/13 05:04

EyePoint Pharmaceuticals | 4：持股变动声明-董事 ADAMIS ANTHONY P

06/26 04:23

EyePoint Pharmaceuticals | 4：持股变动声明-董事 GUYER DAVID R

06/05 04:35

EyePoint Pharmaceuticals | 4：持股变动声明-高管 Elston George

05/29 10:38

EyePoint Pharmaceuticals | 4：持股变动声明-董事 GUYER DAVID R

05/17 05:23

EyePoint Pharmaceuticals | 4：持股变动声明-股东 Cormorant Asset Management, LP

05/09 05:03

EyePoint Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Adage Capital Management, L.P.(9.90%),Robert Atchinson(9.90%)等

05/02 05:12

EyePoint Pharmaceuticals | SC 13G：超过5%持股股东披露文件-Adage Capital Management, L.P.(10.35%),Robert Atchinson(10.35%)等

05/01 08:57